ACET FY 2014 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$68M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$500M+0.0% YoY

Gross Profit

$98M19.7% margin

Operating Income

$34M6.9% margin

Net Income

$22M4.5% margin

EPS (Diluted)

$14.88

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$24M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$468M

Total Liabilities

$234M

Stockholders' Equity

$234M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$500M	$500M	+0.0%
Gross Profit	$98M	$98M	+0.0%
Operating Income	$34M	$34M	+0.0%
Net Income	$22M	$22M	+0.0%